Congressman Tim Ryan Announces Kent State University to Receive $444,238 in Federal Research Funding
Kent, Ohio – Congressman Tim Ryan is announcing $444,238 from the National Institute on Aging of the U.S. Department of Health and Human Services for research on Alzheimer’s Disease to be awarded to Kent State University for a three-year grant.
“The faculty and administration at Kent State University understand the importance of securing federal funding to promote research in areas that can improve people’s lives. If we are going to make advances in the treatment of Alzheimer’s disease, we need to make the right investments—and I am proud of the work that Kent State University does in medical and scientific research,” said Congressman Ryan. “I want to commend Dr. Gemma Casadesus, Associate Professor of Biology at Kent State University for her commitment to this important work and congratulate her on this grant award."
“This award will allow us to better understand how a metabolic hormone, amylin, that shows benefits on memory and Alzheimer's pathology, works,” said Dr. Casadesus. “It will also allow us to better understand how we can use it to prevent Alzheimer's disease in at risk populations such those suffering from metabolic syndrome and/or diabetes. Given the rising increases in these disorders and the lack of optimal tools to diagnose Alzheimer's early enough to treat it, preventive therapies are an important treatment strategy.”
The purpose of the Academic Research Enhancement Award (AREA) program is to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the Nation's research scientists. AREA grants create opportunities for scientists and institutions to contribute to the Nation's biomedical and behavioral research effort.
The National Institute on Aging is one of the 27 Institutes and Centers of the National Institutes of Health, and leads the federal government in conducting and supporting research on aging and the health and well-being of older people. The Institute seeks to understand diseases and conditions associated with growing older, in order to extend the healthy, active years of life. The National Institute on Aging is the primary federal agency for Alzheimer’s disease research.